Publication: Frequency, Distribution, and Impact on Prognosis of BCR-ABL1 Kinase Domain Mutations in Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia Patients
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the BCR
Description
Citation
WoS Q
Scopus Q
Q4
Source
Journal of Experimental and Clinical Medicine (Turkey)
Volume
42
Issue
1
Start Page
48
End Page
52
